PSIFX
Price
$52.39
Change
+$0.36 (+0.69%)
Updated
Jul 31 closing price
Net Assets
913.67M
VFFSX
Price
$366.66
Change
+$2.57 (+0.71%)
Updated
Jul 31 closing price
Net Assets
1.67T
Interact to see
Advertisement

PSIFX vs VFFSX

PSIFX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
PSIFX vs. VFFSX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSIFX is a Buy and VFFSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. PSIFX (914M). VFFSX pays higher dividends than PSIFX: VFFSX (1.08) vs PSIFX (0.98). PSIFX was incepted earlier than VFFSX: PSIFX (34 years) vs VFFSX (10 years). PSIFX (0.32) is less costly to investors than VFFSX (0.01). PSIFX is a more actively managed with annual turnover of: 3.00 vs. VFFSX (2.00). PSIFX has a lower initial minimum investment than VFFSX: PSIFX (0) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 18.19 vs. PSIFX (11.02). VFFSX return over 5 years is better than : 70.69 vs. PSIFX (12.83).
PSIFXVFFSXPSIFX / VFFSX
Total Expense Ratio0.250.012,500%
Annual Report Gross Expense Ratio0.320.013,200%
Fund Existence34 years10 years-
Gain YTD9.9719.467105%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets914M1.67T0%
Annual Yield % from dividends0.981.0891%
Returns for 1 year11.0218.1961%
Returns for 3 years35.6263.9456%
Returns for 5 years12.8370.6918%
Returns for 10 years28.15247.9411%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEDMX57.441.17
+2.08%
Fidelity Advisor Emerging Markets A
HSSCX26.600.10
+0.38%
Emerald Bkg & Finac Evolution - C
PGSGX21.10-0.01
-0.05%
JPMorgan Small Cap Growth A
PQIPX15.59-0.05
-0.32%
PIMCO Dividend and Income I2
BIVRX18.50-0.21
-1.12%
Invenomic Investor